World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
89
Citations
25596
World Ranking
1126
National Ranking
598

Medicine

D-Index
89
Citations
25596
World Ranking
12802
National Ranking
6541

Overview

Pedro A. Piedra is affiliated with Baylor College of Medicine in the United States. The primary fields of study for this researcher are in Medicine, with extensive work specifically in Epidemiology, Infectious Diseases, and Pulmonary and Respiratory Medicine. Additional subfields include Animal Science and Zoology as well as Surgery.

Their research focuses significantly on respiratory viral infections and related topics, including:

  • Respiratory viral infections research
  • SARS-CoV-2 and COVID-19 research
  • Viral gastroenteritis research and epidemiology
  • Influenza virus research studies
  • SARS-CoV-2 detection and testing
  • Neonatal respiratory health research
  • Pneumonia and respiratory infections

Pedro A. Piedra has contributed to multiple recent papers in notable medical journals. Some of the key publications include:

  • "Phase 1-2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine," 2020, published in New England Journal of Medicine
  • "SARS-CoV-2 spike glycoprotein vaccine candidate NVX-CoV2373 immunogenicity in baboons and protection in mice," 2021, published in Nature Communications
  • "Respiratory Syncytial Virus Vaccination during Pregnancy and Effects in Infants," 2020, published in New England Journal of Medicine
  • "Respiratory Syncytial Virus-Associated Hospitalizations Among Young Children: 2015-2016," 2020, published in PEDIATRICS
  • "NVX-CoV2373 vaccine protects cynomolgus macaque upper and lower airways against SARS-CoV-2 challenge," 2020, published in Vaccine

The researcher frequently publishes in venues such as:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Open Forum Infectious Diseases
  • The Journal of Infectious Diseases
  • Nature Communications
  • Vaccine

Pedro A. Piedra has collaborated extensively with other researchers. Frequent co-authors include:

  • Vasanthi Avadhanula
  • Geoffrey A. Weinberg
  • Rangaraj Selvarangan
  • Natasha Halasa
  • Janet A. Englund

Best Publications

  • Phase 1-2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine.

    Cheryl Keech;Gary Albert;Iksung Cho;Andreana Robertson

  • The Efficacy of Live Attenuated, Cold-Adapted, Trivalent, Intranasal Influenzavirus Vaccine in Children

    Robert B. Belshe;Paul M. Mendelman;John Treanor;James King

  • Impact of respiratory virus infections on persons with chronic underlying conditions.

    W P Glezen;S B Greenberg;R L Atmar;P A Piedra

  • Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine.

    Robert B. Belshe;William C. Gruber;Paul M. Mendelman;Iksung Cho

  • Administration of helper-dependent adenoviral vectors and sequential delivery of different vector serotype for long-term liver-directed gene transfer in baboons

    Núria Morral;Wanda O’Neal;Karen Rice;Michele Leland

  • Prospective Multicenter Study of Viral Etiology and Hospital Length of Stay in Children With Severe Bronchiolitis

    Jonathan M. Mansbach;Pedro A. Piedra;Stephen J. Teach;Ashley F. Sullivan

  • Correlates of Immune Protection Induced by Live, Attenuated, Cold-Adapted, Trivalent, Intranasal Influenza Virus Vaccine

    Robert B. Belshe;William C. Gruber;Paul M. Mendelman;Harshvardhan B. Mehta

  • SARS-CoV-2 spike glycoprotein vaccine candidate NVX-CoV2373 immunogenicity in baboons and protection in mice.

    Jing Hui Tian;Nita Patel;Robert Haupt;Haixia Zhou

  • The respiratory syncytial virus vaccine landscape: lessons from the graveyard and promising candidates.

    Natalie I Mazur;Deborah Higgins;Marta C Nunes;José A Melero

  • Circulation Patterns of Group A and B Human Respiratory Syncytial Virus Genotypes in 5 Communities in North America

    Teresa C. T. Peret;Caroline B. Hall;Gregory W. Hammond;Pedro A. Piedra

  • Influenza Vaccine Effectiveness in the 2011–2012 Season: Protection Against Each Circulating Virus and the Effect of Prior Vaccination on Estimates

    Suzanne E. Ohmit;Mark G. Thompson;Joshua G. Petrie;Swathi N. Thaker

  • Respiratory Syncytial Virus Vaccination during Pregnancy and Effects in Infants

    Shabir A Madhi;Fernando P Polack;Pedro A Piedra;Flor M Munoz

  • Herd immunity in adults against influenza-related illnesses with use of the trivalent-live attenuated influenza vaccine (CAIV-T) in children.

    Pedro A. Piedra;Manjusha J. Gaglani;Claudia A. Kozinetz;Gayla Herschler

  • Influenza virus infections in infants.

    W. Glezen;Larry Taber;Arthur Frank;William Gruber

  • Influenza Vaccine Effectiveness in the United States During 2012–2013: Variable Protection by Age and Virus Type

    Huong Q. McLean;Mark G. Thompson;Maria E. Sundaram;Burney A. Kieke

  • Lifetime correction of genetic deficiency in mice with a single injection of helper-dependent adenoviral vector

    In-Hoo Kim;Alicja Józkowicz;Pedro A. Piedra;Kazuhiro Oka

  • Safety and immunogenicity of respiratory syncytial virus purified fusion protein-2 vaccine in pregnant women.

    Flor M Munoz;Pedro A Piedra;W Paul Glezen

  • Generation and Characterization of ALX-0171, a Potent Novel Therapeutic Nanobody for the Treatment of Respiratory Syncytial Virus Infection

    Laurent Detalle;Thomas Stohr;Concepción Palomo;Pedro A. Piedra

  • Correlates of immunity to respiratory syncytial virus (RSV) associated-hospitalization: establishment of minimum protective threshold levels of serum neutralizing antibodies

    Pedro A. Piedra;Alan M. Jewell;Stanley G. Cron;Robert L. Atmar

  • Disseminated Adenovirus Disease in Immunocompromised and Immunocompetent Children

    Flor M. Munoz;Pedro A. Piedra;Gail J. Demmler

  • Effects of viral lower respiratory tract infection on lung function in infants with cystic fibrosis

    Peter W. Hiatt;Susan C. Grace;Claudia A. Kozinetz;Soufia Helioui Raboudi

Frequent Co-Authors

Carlos A. Camargo
Carlos A. Camargo Harvard University
Manjusha Gaglani
Manjusha Gaglani Baylor College of Medicine
Brian E. Gilbert
Brian E. Gilbert Baylor College of Medicine
Joseph F. Petrosino
Joseph F. Petrosino Baylor College of Medicine
Janet A. Englund
Janet A. Englund Seattle Children's Hospital
L F Fries
L F Fries Novavax (United States)
James E. Gern
James E. Gern University of Wisconsin–Madison
Nadim J. Ajami
Nadim J. Ajami The University of Texas MD Anderson Cancer Center
Alicia M. Fry
Alicia M. Fry Emory University
Chad A. Shaw
Chad A. Shaw Baylor College of Medicine

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing immunology opens doors to various health science careers, many of which can be enhanced or supported through online degree programs. For those interested in nursing as a pathway, several online options offer flexible entry points. Exploring the easiest absn to get into can help students transition quickly into the nursing field while balancing other commitments.

For prospective nurses seeking foundational qualifications, the lpn programs easy to get into provide accessible routes with shorter timelines. These programs often serve as a stepping stone toward advanced clinical roles aligned with immunology-related healthcare specialties.

Advancing further, those looking to specialize clinically in immunology-related patient care might consider programs listed among the easiest online nurse practitioner programs. These degrees prepare nurses for autonomous practice, often emphasizing advanced pathophysiology and immunological knowledge essential for treating immune-related conditions.

Finally, for professionals focused on mental health’s intersection with immune function, best online pmhnp programs offer exceptional clinical placement opportunities. These programs support the development of expertise critical to addressing psychoneuroimmunology in patient care.

Best Scientists Citing Pedro A. Piedra

Trending Scientists